Summary
IDEXX Laboratories, Inc. filed its 2009 10-K on February 18, 2010, detailing its business operations, financial performance, and risk factors for the fiscal year ending December 30, 2009. The company operates in the veterinary diagnostics and animal health industry. Investors should pay close attention to Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, which provides critical insights into the company's performance drivers, strategic initiatives, and outlook. The report also incorporates by reference its definitive proxy statement for the upcoming 2010 Annual Meeting, which will contain further details on corporate governance and executive compensation. While specific financial figures are not detailed in the provided excerpt, the structure of the 10-K indicates a comprehensive review of IDEXX's business segments, competitive landscape, and any material risks or legal proceedings that could impact its future profitability and market position. Investors are encouraged to review the full filing, particularly the financial statements and MD&A, to understand the company's financial health and strategic direction.
Financial Highlights
51 data points| Revenue | $1.03B |
| Cost of Revenue | $505.35M |
| Gross Profit | $526.28M |
| R&D Expenses | $65.12M |
| Operating Income | $175.97M |
| Interest Expense | $1.92M |
| Net Income | $122.22M |
| EPS (Basic) | $1.04 |
| EPS (Diluted) | $1.00 |
| Shares Outstanding (Basic) | 117.62M |
| Shares Outstanding (Diluted) | 121.36M |
Key Highlights
- 1The 10-K report covers the fiscal year ending December 30, 2009, for IDEXX Laboratories, Inc.
- 2The filing incorporates by reference portions of the company's definitive proxy statement for the 2010 Annual Meeting to be held on May 5, 2010.
- 3Key sections for investors include Item 1 (Business), Item 1A (Risk Factors), Item 6 (Selected Financial Data), and Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations).
- 4The report outlines the company's business segments, properties, and any legal proceedings.
- 5Information regarding market for registrant's common equity, related stockholder matters, and issuer purchases of equity securities is provided in Item 5.
- 6Controls and procedures related to financial reporting are detailed in Item 9A.
- 7Information on directors, executive officers, corporate governance, executive compensation, and security ownership is located in Part III.